Goldman Sachs’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,882
Closed -$380K 6466
2025
Q3
$380K Buy
+23,882
New +$393K ﹤0.01% 5650
2025
Q2
Sell
-14,446
Closed -$301K 6103
2025
Q1
$301K Buy
+14,446
New +$274K ﹤0.01% 5456
2024
Q3
Sell
-20,105
Closed -$394K 5829
2024
Q2
$394K Buy
20,105
+447
+2% +$8.48K ﹤0.01% 4951
2024
Q1
$354K Sell
19,658
-6,291
-24% -$114K ﹤0.01% 4896
2023
Q4
$440K Buy
+25,949
New +$516K ﹤0.01% 4833
2023
Q2
Sell
-51,103
Closed -$1.04M 5766
2023
Q1
$1.04M Sell
51,103
-5,945
-10% -$120K ﹤0.01% 4355
2022
Q4
$1.21M Buy
+57,048
New +$1.18M ﹤0.01% 4297
2020
Q1
Sell
-24,674
Closed -$547K 5214
2019
Q4
$547K Sell
24,674
-1,600
-6% -$37.1K ﹤0.01% 4454
2019
Q3
$623K Hold
26,274
﹤0.01% 4337
2019
Q2
$576K Buy
+26,274
New +$573K ﹤0.01% 4320
2016
Q3
Sell
-24,540
Closed -$571K 7020
2016
Q2
$571K Hold
24,540
﹤0.01% 4732
2016
Q1
$542K Hold
24,540
﹤0.01% 4667
2015
Q4
$507K Buy
+24,540
New +$501K ﹤0.01% 4909

Other funds holding BTAL

Goldman Sachs's BTAL Position: Q4 2025 in Review

Goldman Sachs sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 23,882 shares — an estimated $380K sold.

Goldman Sachs first reported a position in BTAL in Q4 2015 and held it in 13 quarters. The position peaked at $1.21M in Q4 2022. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

  • Goldman Sachs reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
  • Goldman Sachs sold 23,882 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $380K.
  • Goldman Sachs first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2015 and held it in 13 quarters.
  • Goldman Sachs's AGF US Market Neutral Anti-Beta Fund position peaked at $1.21M in Q4 2022.
  • 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.